TRAX

41.6406.34%
AA

Ajim A. Tamboli

Chief Financial Officer

Mr. Ajim A. Tamboli, CFA is Chief Financial Officer of First Tracks Biotherapeutics, Inc. from April 20, 2026. Mr. Tamboli was Chief Financial Officer of ADARx Pharmaceuticals, Inc. from July 2024 to 2025. He was responsible for leading financial operations while supporting strategic initiatives and business operations. He also leads efforts in Business Development, Investor Relations and Facilities. He was Chief Financial Officer of Arbor Biotechnologies, Inc. from August 2023. He joined Arbor Biotechnologies, Inc. in August 2023. He served as Chief Financial Officer at Monte Rosa Therapeutics, Inc. since September 2020 until 2023. He had been the Chief Financial Officer of Rodin Therapeutics Inc. since August 6, 2019 until 2020. He served as a Partner of Asymmetry Capital Management, L.P., since 2018 until 2019. He served as a Partner at Endurant Capital Management LP since 2013 until 2018. He was employed at J. & W. Seligman & Co. Incorporated. From 2010 until 2013, he was a life sciences Investor with Columbia Management Group. He was a Senior Portfolio Manager at Hovan Capital Management, LLC. He served at Lehman Brothers Holdings Inc., where he served as a Senior Equity Research Analyst of the biotechnology sector from 2003 to 2008, where he led coverage and co-coverage of 36 biotechnology companies and conducted research and analysis of over 200 additional publicly traded and private biopharmaceutical companies. His previous experience includes a Consultant and Analyst at Duquesne Capital from 2002 to 2003 and an Equity Research Analyst at Credit Suisse First Boston from 2000 to 2001. He served as Senior Equity Research Analyst at Barclays Capital, Research Division. He earned his Chartered Financial Analyst designation in 2003. He received his M.S. in Biotechnology in 2002 and a B.S. in Biomedical Science/Entrepreneurial Management in 1998 from University of Pennsylvania School of Engineering and Applied Science and from Wharton School of Business, University of Pennsylvania, where he was a Benjamin Franklin Scholar.

Positions